Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maja Bujas-Bobanovic
Lipoprotein(a) Reductions From PCSK9 Inhibition and Major Adverse Cardiovascular Events: Pooled Analysis of Alirocumab Phase 3 Trials
Atherosclerosis
Cardiovascular Medicine
Cardiology
Related publications
Efficacy and Safety of Alirocumab in Patients With or Without Prior Coronary Revascularization: Pooled Analysis of Eight ODYSSEY Phase 3 Trials
Atherosclerosis
Cardiovascular Medicine
Cardiology
Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Derived From a Pooled Analysis of 3958 Patients
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Predictors of Adverse Events Among Patients Undergoing Primary Percutaneous Coronary Intervention: Insights From a Pooled Analysis of the COMFORTABLE AMI and EXAMINATION Trials
EuroIntervention
Medicine
Cardiovascular Medicine
Cardiology
Major Adverse Cardiovascular Events in Treated Periodontitis: A Population-Based Follow-Up Study From Taiwan
PLoS ONE
Multidisciplinary
Association of Non-Alcoholic Fatty Liver Disease With Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
Scientific Reports
Multidisciplinary
Cardiovascular Risks, Bleeding Risks, and Clinical Events From 3 Phase III Trials of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
Advances in Therapy
Medicine
Pharmacology
Prognostic Value of Plasma Von Willebrand Factor Levels in Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
BMC Cardiovascular Disorders
Cardiovascular Medicine
Cardiology
Delayed Adverse Events in Phase I Trials of Molecularly Targeted and Cytotoxic Agents
Oncotarget
Oncology
Preventing Major Adverse Cardiovascular Events by SGLT-2 Inhibition in Patients With Type 2 Diabetes: The Role of Kidney
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
